Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma	B-cell neoplasm, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Infections, Neoplasms by Histologic Type, RNA Virus Infections, Urogenital Diseases, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, lentivirus infection, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Recruiting	Phase 1	2026-07-10		NCT05077527

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AIDS Malignancy Consortium	11
Memorial Sloan Kettering Cancer Center	753
National Cancer Institute (NCI)	3015

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
City of Hope Comprehensive Cancer Center	Duarte	United States	263
Huntsman Cancer Institute, University of Utah	Salt Lake City	United States	45
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Montefiore Medical Center - Moses Campus	The Bronx	United States	219
The Ohio State University	Columbus	United States	191
University of Illinois at Chicago	Chicago	United States	85
University of Pennsylvania / Abramson Cancer Center	Philadelphia	United States	2